News Releases

Beth McLellan, M.D., Named Chief of the Division of Dermatology at Einstein and Montefiore
NIH Awards Training Grant for Research on Intellectual and Developmental Disabilities
$111 Million NIH Grant Awarded to Prevent and Treat HIV-Associated Cancers

Facts & Stats

Published Papers
NIH Research Funding
Full-time Faculty
Global Initiatives
Clinical and Research Centers

Expert List for Media

Felise B. Milan

Felise B. Milan, M.D.

Area(s) of expertise: Medical educationClinical trainingClinical skills

Dr. Milan specializes in the education of medical students, including teaching and assessing communication and interpersonal skills in a clinical setting. She has participated in research to define and develop ways of assessing… Learn more

Einstein in the News

NIH Diabetes Discoveries & Practice Blog
The Role of the Community Environment in Managing Diabetes Risk

Earle Chambers, Ph.D., M.P.H., discusses social and economic conditions—such as barriers to accessing healthy food, stable housing, and safe recreational areas—and how these factors affect patients' ability to manage their risk of developing diabetes. Dr. Chambers is director of the division of research in the department of family and social medicine and associate professor of family and social medicine and of epidemiology & population health at Einstein and Montefiore.

Researchers Learning More About How the Coronavirus Sabotages Blood Vessels

Gaetano Santulli, M.D., Ph.D., comments on the damage caused by COVID-19 to the cells that line blood vessels and the resulting increased risk of blood clots throughout the body. Dr. Santulli is assistant professor of medicine and of molecular pharmacology.

Apathy Could Lead to a Greater Risk of Dementia, Study Finds

Joe Verghese, M.B.B.S., M.S., comments on a study that found apathy in older adults could be a risk factor for dementia and notes his prior research suggests that addressing apathy could help delay the onset of dementia. Dr. Verghese is chief of geriatrics at Einstein and Montefiore and director of the Montefiore Einstein Center for the Aging Brain.

More coverage on Dr. Verghese


When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos

The Doctor's Tablet Blog